A new minimally invasive treatment to repair aortic aneurysms involving the visceral vessels could expand the treatment options available for patients, shorten the time it takes to receive treatment and reduce recovery time.
A new type of stent graft being tested at Ohio State for the next two years could be a game-changer in aortic surgery, says vascular surgeon Timur Sarac, MD.
Theo Tammy Trialing is a new medical device made by W. L. Gore that allows us to treat patients with Thor IQ, abdominal aortic aneurysms and Perry visceral aortic aneurysms with a new, minimally invasive stent graft, which has a prefabricated mechanism toe, put inside branches that continue profusion to the blood vessels of the visceral organs that is the celiac artery sm and kidney arteries. And those are the arteries that are vital for maintaining function. Traditionally, the treatment of these patients involves a new decision. Were extends from the outside of your chest on the left side, all the way down to your umbilicus. It's a major incision we have toe. Take out one of the ribs on DWI, interrupt blood flow for a period of time to the organ systems, and sometimes even put the patient on the heart lung bypass machines. If we're gonna opt for a minimally invasive approach again, there's no commercially available device, so we have Thio improvise as we go along, and that involves large incision underneath the clavicle, along with two incisions in the groin. That procedure takes approximately 6 to 7 hours, as the graphs have to be individually determined the length and appropriate, uh, position as your on the table, and that as a significant amount of time to the case. In addition to radiation to the patient, the new device, those branches that we are pre custom designed and developed to fit to the patients so that when we take them to the table, we can take and eliminate all those extra procedures. This involves three small incisions. In addition, the patient procedure actually only takes about 2.5 to 3 hours. We're continuing toe enroll our patients in this trial, and this is a combined trial with cardiac surgery and vascular surgery tradition. It's a multidisciplinary approach that we have a cardiology team helping us get the patients ready for surgery. The next steps also in treating these patients are continue to screen patients within the community who are eligible for the study. This is an exciting time in Ohio State because we do have a new aortic center. It offers us an opportunity toe, provide patients with a combined multi multi disciplinary approach to their complex problems, where we can tailor the treatment to their problems.
Related Presenters
